Global Psoriasis Treatment Drugs Market Opportunities and Forecast 2022-2028

Global Psoriasis Treatment Drugs Market Opportunities and Forecast 2022-2028

Report Code: KNJ1355231 | No. of Pages: | Category: Pharmaceuticals and Healthcare
Publisher: GRD Survey | Date of Publish: Jul-2022
This report provides a comprehensive analysis of current global Psoriasis Treatment Drugs market based on segmented types and downstream applications. Major product development trends are discussed  under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Psoriasis Treatment Drugs industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to GRD Survey, the global Psoriasis Treatment Drugs market is estimated at $  million in 2021, and projected to grow at a CAGR of % to $  million by 2028.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Psoriasis Treatment Drugs Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Psoriasis Treatment Drugs market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Psoriasis Treatment Drugs Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Psoriasis Treatment Drugs industry. 
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis. 
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions


Segmented by Type
    TNF Inhibitors

    Interleukin Inhibitors


Segmented by Application
    Oral

    Parenteral

    Topical


Segmented by Country
    North America
        United States
        Canada
        Mexico
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
    Asia Pacific
        China
        Japan
        Korea
        Southeast Asia
        India
        Australasia
    Central & South America
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Iran
        Israel
        Turkey
        South Africa
        Saudi Arabia

Key manufacturers included in this survey
    Merck

    LEO Pharma

    Johnson & Johnson

    Galectin Therapeutics

    Eli Lilly

    Dermira

    Cellceutix

    Biogen

    Bayer

    AstraZeneca

    Amgen

    Allergan

    AbbVie



Table of Contents

1 Product Introduction and Overview
    1.1 Product Definition
    1.2 Product Specification
    1.3 Global Market Overview
        1.3.1 Global Psoriasis Treatment Drugs Market Status and Forecast (2017-2028)
        1.3.2 Global Psoriasis Treatment Drugs Sales Value CAGR by Region
    1.4 Market Drivers, Inhibitors
        1.4.1 Market Drivers
        1.4.2 Market Inhibitors
        1.4.3 COVID-19 Impact Analysis
2 Global Psoriasis Treatment Drugs Supply by Company
    2.1 Global Psoriasis Treatment Drugs Sales Volume by Company
    2.2 Global Psoriasis Treatment Drugs Sales Value by Company
    2.3 Global Psoriasis Treatment Drugs Price by Company
    2.4 Psoriasis Treatment Drugs Production Location and Sales Area of Main Manufacturers
    2.5 Trend of Concentration Rate
3 Global and Regional Psoriasis Treatment Drugs Market Status by Type
    3.1 Psoriasis Treatment Drugs Type Introduction
        3.1.1 TNF Inhibitors

        3.1.2 Interleukin Inhibitors

        3.1.3 Vitamin D Analogs

        3.1.4 Corticosteroids

        3.1.5 Others

    3.2 Global Psoriasis Treatment Drugs Market by Type
        3.2.1 Global Psoriasis Treatment Drugs Sales Volume by Type (2017-2022)
        3.2.2 Global Psoriasis Treatment Drugs Sales Value by Type (2017-2022)
        3.2.3 Global Psoriasis Treatment Drugs Price by Type (2017-2022)
    3.3 North America: by Type
    3.4 Europe: by Type
    3.5 Asia Pacific: by Type
    3.6 Central & South America: by Type
    3.7 Middle East & Africa: by Type
4 Global and Regional Psoriasis Treatment Drugs Market Status by Application
    4.1 Psoriasis Treatment Drugs Segment by Application
        4.1.1 Oral

        4.1.2 Parenteral

        4.1.3 Topical

    4.2 Global Psoriasis Treatment Drugs Market by Application
        4.2.1 Global Psoriasis Treatment Drugs Sales Volume by Application (2017-2022)
        4.2.2 Global Psoriasis Treatment Drugs Sales Value by Application (2017-2022)
        4.2.3 Global Psoriasis Treatment Drugs Price by Application (2017-2022)
    4.3 North America: by Application
    4.4 Europe: by Application
    4.5 Asia Pacific: by Application
    4.6 Central & South America: by Application
    4.7 Middle East & Africa: by Application
5 Global Psoriasis Treatment Drugs Market Status by Region
    5.1 Global Psoriasis Treatment Drugs Market by Region
        5.1.1 Global Psoriasis Treatment Drugs Sales Volume by Region
        5.1.2 Global Psoriasis Treatment Drugs Sales Value by Region
    5.2 North America Psoriasis Treatment Drugs Market Status
    5.3 Europe Psoriasis Treatment Drugs Market Status
    5.4 Asia Pacific Psoriasis Treatment Drugs Market Status
    5.5 Central & South America Psoriasis Treatment Drugs Market Status
    5.6 Middle East & Africa Psoriasis Treatment Drugs Market Status
6 North America Psoriasis Treatment Drugs Market Status
    6.1 North America Psoriasis Treatment Drugs Market by Country
        6.1.1 North America Psoriasis Treatment Drugs Sales Volume by Country (2017-2022)
        6.1.2 North America Psoriasis Treatment Drugs Sales Value by Country (2017-2022)
    6.2 United States
    6.3 Canada
    6.4 Mexico
7 Europe Psoriasis Treatment Drugs Market Status
    7.1 Europe Psoriasis Treatment Drugs Market by Country
        7.1.1 Europe Psoriasis Treatment Drugs Sales Volume by Country (2017-2022)
        7.1.2 Europe Psoriasis Treatment Drugs Sales Value by Country (2017-2022)
    7.2 Germany
    7.3 France
    7.4 UK
    7.5 Italy
    7.6 Russia
    7.7 Spain
8 Asia Pacific Psoriasis Treatment Drugs Market Status
   8.1 Asia Pacific Psoriasis Treatment Drugs Market by Country
        8.1.1 Asia Pacific Psoriasis Treatment Drugs Sales Volume by Country (2017-2022)
        8.1.2 Asia Pacific Psoriasis Treatment Drugs Sales Value by Country (2017-2022)
    8.2 China
    8.3 Japan
    8.4 Korea
    8.5 Southeast Asia
    8.6 India
    8.7 Australasia
9 Central & South America Psoriasis Treatment Drugs Market Status
    9.1 Central & South America Psoriasis Treatment Drugs Market by Country
        9.1.1 Central & South America Psoriasis Treatment Drugs Sales Volume by Country (2017-2022)
        9.1.2 Central & South America Psoriasis Treatment Drugs Sales Value by Country (2017-2022)
    9.2 Brazil
    9.3 Argentina
    9.4 Colombia
10 Middle East & Africa Psoriasis Treatment Drugs Market Status
    10.1 Middle East & Africa Psoriasis Treatment Drugs Market by Country
        10.1.1 Middle East & Africa Psoriasis Treatment Drugs Sales Volume by Country (2017-2022)
        10.1.2 Middle East & Africa Psoriasis Treatment Drugs Sales Value by Country (2017-2022)
    10.2 Iran
    10.3 Israel
    10.4 Turkey
    10.5 South Africa
    10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
    11.1 Supply Chain Analysis
    11.2 Production Process Chart Analysis
    11.3 Raw Materials and Key Suppliers Analysis
        11.3.1 Raw Materials Introduction
        11.3.2 Raw Materials Key Suppliers List
    11.4 Psoriasis Treatment Drugs Manufacturing Cost Analysis
    11.5 Psoriasis Treatment Drugs Sales Channel and Distributors Analysis
        11.5.1 Psoriasis Treatment Drugs Sales Channel
        11.5.2 Psoriasis Treatment Drugs Distributors
    11.6 Psoriasis Treatment Drugs Downstream Major Buyers
12 Global Psoriasis Treatment Drugs Market Forecast by Type and by Application
    12.1 Global Psoriasis Treatment Drugs Sales Volume and Sales Value Forecast (2023-2028)
    12.2 Global Psoriasis Treatment Drugs Forecast by Type
        12.2.1 Global Psoriasis Treatment Drugs Sales Volume Forecast by Type
        12.2.2 Global Psoriasis Treatment Drugs Sales Value Forecast by Type
        12.2.3 Global Psoriasis Treatment Drugs Price Forecast by Type
    12.3 Global Psoriasis Treatment Drugs Forecast by Application
        12.3.1 Global Psoriasis Treatment Drugs Sales Volume Forecast by Application
        12.3.2 Global Psoriasis Treatment Drugs Sales Value Forecast by Application
        12.3.3 Global Psoriasis Treatment Drugs Price Forecast by Application
13 Global Psoriasis Treatment Drugs Market Forecast by Region/Country
    13.1 Global Psoriasis Treatment Drugs Market Forecast by Region (2023-2028)
        13.1.1 Global Psoriasis Treatment Drugs Sales Volume Forecast by Region (2023-2028)
        13.1.2 Global Psoriasis Treatment Drugs Sales Value Forecast by Region (2023-2028)
    13.2 North America Market Forecast
    13.3 Europe Market Forecast
    13.4 Asia Pacific Market Forecast
    13.5 Central & South America Market Forecast
    13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
    14.1 Pfizer

        14.1.1 Company Information
        14.1.2 Psoriasis Treatment Drugs Product Introduction
        14.1.3 Pfizer
 Psoriasis Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
        14.1.4 SWOT Analysis
    14.2 Novartis

        14.2.1 Company Information
        14.2.2 Psoriasis Treatment Drugs Product Introduction
        14.2.3 Novartis
 Psoriasis Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
        14.2.4 SWOT Analysis
    14.3 Merck

        14.3.1 Company Information
        14.3.2 Psoriasis Treatment Drugs Product Introduction
        14.3.3 Merck
 Psoriasis Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
        14.3.4 SWOT Analysis
    14.4 LEO Pharma

        14.4.1 Company Information
        14.4.2 Psoriasis Treatment Drugs Product Introduction
        14.4.3 LEO Pharma
 Psoriasis Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
        14.4.4 SWOT Analysis
    14.5 Johnson & Johnson

        14.5.1 Company Information
        14.5.2 Psoriasis Treatment Drugs Product Introduction
        14.5.3 Johnson & Johnson
 Psoriasis Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
        14.5.4 SWOT Analysis
    14.6 Galectin Therapeutics

        14.6.1 Company Information
        14.6.2 Psoriasis Treatment Drugs Product Introduction
        14.6.3 Galectin Therapeutics
 Psoriasis Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
        14.6.4 SWOT Analysis
    14.7 Eli Lilly

        14.7.1 Company Information
        14.7.2 Psoriasis Treatment Drugs Product Introduction
        14.7.3 Eli Lilly
 Psoriasis Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
        14.7.4 SWOT Analysis
    14.8 Dermira

        14.8.1 Company Information
        14.8.2 Psoriasis Treatment Drugs Product Introduction
        14.8.3 Dermira
 Psoriasis Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
        14.8.4 SWOT Analysis
    14.9 Cellceutix

        14.9.1 Company Information
        14.9.2 Psoriasis Treatment Drugs Product Introduction
        14.9.3 Cellceutix
 Psoriasis Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
        14.9.4 SWOT Analysis
    14.10 Biogen

        14.10.1 Company Information
        14.10.2 Psoriasis Treatment Drugs Product Introduction
        14.10.3 Biogen
 Psoriasis Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
        14.10.4 SWOT Analysis
    14.11 Bayer

    14.12 AstraZeneca

    14.13 Amgen

    14.14 Allergan

    14.15 AbbVie

15 Conclusion
16 Methodology

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com